3-CPM Stats & Data

- Identity: 3-CPM is a phenylmorpholine stimulant closely related to phenmetrazine and 3‑FPM; it has no established human pharmacokinetics, so interindividual variability and supply purity are major risks. Use small allergy tests and a calibrated milligram scale.

- Potency/compulsion: Users frequently report a strong urge to redose, especially via intranasal or vaporized routes. Planning dose limits and spacing sessions reduces binge risk and residual insomnia.

- Cardiovascular strain: Like other stimulants, it can raise heart rate and blood pressure and cause vasoconstriction; people with cardiovascular disease, hypertension, or risk factors should avoid it. Seek medical care for chest pain, severe headache, or persistent tachycardia.

- Nasal harm: Intranasal use is often described as extremely caustic with burning pain lasting 20–40 minutes; repeated lines increase epistaxis and septal damage risk. If choosing to snort, finely pulverize, use personal sterile straws, pre/post-rinse with isotonic saline, rotate nostrils, and take long breaks.

- Pulmonary irritation: Vaporizing/smoking has been reported to cause harsh throat/lung irritation; unknown pyrolysis products may add risk. Avoid high-temperature hits and large boluses; oral ROA is safer for tissues.

- Sleep/comedown: Residual stimulation commonly impairs sleep. Avoid late-day dosing; plan 24 h of recovery time, nutrition, and sleep hygiene.

- Hydration/temperature: Stimulants increase core temperature and sweat. Sip ~250 mL water/hour at rest (up to 500 mL/hour if active) with electrolytes; take cooling breaks, and avoid hot environments.

- Serotonergic combinations: Combining with MDMA, tramadol, or serotonergic antidepressants increases serotonin-toxicity risk (agitation, clonus, hyperthermia); avoid.

- Seizure threshold: Tramadol and stimulant co-use raises seizure risk; avoid this combination.

- Testing/purity: Reagents may not distinguish phenylmorpholine analogs; where available, use lab-based drug checking or spectrometric services. Avoid unknown vendors.

- Drug testing: Phenmetrazine analogs may trigger amphetamine-class immunoassay positives; confirmatory testing distinguishes them but is not routine.

- Storage: Keep powders in airtight, dry, dark containers; minimize oxygen and heat exposure. Let sealed containers warm to room temperature before opening to prevent condensation.